Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 176 results found. Search for [ CDSCO ]

Results 60 to 80 of 176
BusinessToday.In
August 22, 2020
Bharat Biotech has received nod to conduct the Phase I and II clinical trial of its COVID-19 vaccine 'Covaxin' through intradermal route, which is just under the skin


BusinessToday.In
August 3, 2020
Coronavirus vaccine news update: Pharmaceutical giant AstraZeneca has also said that coronavirus might require annual vaccination. CEO Pascal Soriot said that the virus is 'very unpredictable'


PTI
August 3, 2020
Currently, phase 2 and 3 clinical trials of the Oxford vaccine candidate is going on in the United Kingdom, phase 3 clinical trial in Brazil and phase 1 and 2 clinical trials in South Africa


BusinessToday.In
August 2, 2020
Coronavirus vaccine: The Russian vaccine has raised concerns because of the speed at which it is being pushed through. However, the Russian Defence Ministry clarified that tests of the vaccine against coronavirus were conducted in full compliance with methodological regulations


BusinessToday.In
July 30, 2020
Coronavirus vaccine news update: Serum Institute of India has been asked by Drug Controller General of India (DCGI) to change its protocol for Phase 2 and 3 trials of Oxford University-AstraZeneca COVID-19 vaccine


BusinessToday.In
July 29, 2020
The subject expert committee for COVID-19 related proposals under Central Drugs Standards Control Organisation (CDDSCO) asked Serum Institute to submit revised protocol for evaluation


BusinessToday.In
July 27, 2020
Avra Lab has developed an alternative low-cost and highly efficient manufacturing process and is now supplying commercial quantities to Cipla for the launch of Ciplenza, the generic version of Favipiravir


Joe C Mathew
July 9, 2020
Instructions, prepared by Drugs Controller General of India (DCGI), were intended to reduce red-tapeism or procedural delays


PTI
July 9, 2020
Fauci said hopefully we'll be able to get some information, such as with this particular one representative vaccine that we started here in January


PTI
July 8, 2020
During blood purification therapy, the patient's blood passes through the Oxiris filter set, where it can adsorb inflammatory mediators, and remove fluid, electrolytes and uremic toxins, before returning the patient's blood to the body, Baxter India said


PB Jayakumar
July 8, 2020
Various medical shops have been telling buyers that the medicine is in short supply but can be made available If they are ready to pay a premium, DCGI has been informed


Joe C Mathew
July 7, 2020
DGCI has asked all state drug controllers to instruct their field officials to keep strict vigil to prevent black marketing and unauthorised sale of remdesivir


BusinessToday.In
July 6, 2020
At present, Telangana Delhi, Maharashtra and Rajasthan governments have capped the cost of COVID-19 test at Rs 2,200 at private labs. Whereas, West Bengal has capped the cost of COVID-19 testing to Rs 2,250 at private laboratories


Joe C Mathew
July 5, 2020
A Vigyan Prasar article claimed that none of the coronavirus vaccines under development around the world, including India, would be available for mass use before 2021; PIB omitted this warning while carrying this article on its portal


E Kumar Sharma
July 3, 2020
Zydus Cadila is second in India after Bharat Biotech to receive DCGI nod for human trials of vaccine candidate


Joe C Mathew
July 2, 2020
\"Availability and monitoring of prices of critical medical equipment for COVID-19 was on the agenda of the meeting\", an industry representative said


BusinessToday.In
June 30, 2020
Coronavirus vaccine update: The Hyderabad-based vaccine major's vaccine candidate COVAXIN has received permission for advancing to human trials


Associated Press
June 13, 2020
Four companies -- Hetero, Jubilant Life Sciences, Cipla and Mylan NV -- with which the original drug maker, Gilead Sciences Inc, have entered into non-exclusive licensing agreements are still awaiting nod from the DCGI for manufacturing and selling of remdesivir in India


BusinessToday.In
New Delhi, June 8, 2020
Coronavirus treatment: DCGI has asked the five companies concerned to furnish various sets of data including animal toxicity, stability study etc


PTI
June 2, 2020
The drug has been allowed for restricted emergency use for treatment of suspected or laboratory-confirmed cases of COVID-19 in adults and children hospitalised with severe symptoms, subject to several safeguards, the source said


PAGES 4 OF 9  12345